Cyclin G2 Expression in Gastric-cancer Tissues.
10.5230/jkgca.2005.5.4.273
- Author:
Min Gew CHOI
1
;
Seong Kweon HONG
;
Sung Bae PARK
;
Yong Hae PAIK
;
Jae Hyung NOH
;
Tae Sung SOHN
;
Sung Joo KIM
;
Sung KIM
Author Information
1. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. sungkimm@smc.samsung.co.kr
- Publication Type:Original Article
- Keywords:
Gastric cancer;
Cyclin G2
- MeSH:
Carcinogenesis;
Cyclin G2*;
Cyclins*;
Humans;
Multivariate Analysis;
Neoplasm Metastasis;
Prognosis;
Stomach Neoplasms
- From:Journal of the Korean Gastric Cancer Association
2005;5(4):273-280
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Cyclin G2 has been reported to be a negative cell-cycle regulator in various cancer tissues. However, the pattern of cyclin G2 expression in gastric cancer is relatively unknown. We investigated the expression of cyclin G2 in gastric cancer tissues and evaluated the clinical significance of its expression. MATERIALS AND METHODS: Well-preserved gastric cancer tissues were consecutively obtained from 172 patients who underwent gastric cancer operations at Samsung Medical Center between November 1994 and December 1997. Cyclin G2 expression in the tissues was examined immunohistochemically, and the clinicopathological features and prognostic significance according to the expression were analyzed. RESULTS: Of the 172 gastric cancer tissues, cyclin G2 expression was positive in 43 tissues (25.0%). According to the stage, cyclin G2 expression was lower in more advanced stages (P<0.001). Negative expression of cyclin G2 was positively correlated with more advanced depth of tumor invasion (P<0.05), presence of lymph-node metastasis (P<0.05) and presence of lymphatic invasion (P<0.05). The prognosis of the cyclin G2 (+) group was significantly better than that of the cyclin G2 (-) group (P<0.001). Multivariate analysis revealed that T stage, lymph-node metastasis, distant metastasis, and lymphatic invasion were independent prognostic factors, but the expression of cyclin G2 was not. CONCLUSION: Cyclin G2 was expressed in 25% of the gastric cancer tissues, and negative expression of cyclin G2 was associated with more advanced tumor progression. Cyclin G2 may be a negative cell-cycle regulator in gastric cancer, and further studies are necessary to elucidate its exact role in the mechanism of carcinogenesis.
